Knoll Capital Management LLC 13D and 13G filings for Corbus Pharmaceuticals Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-16 10:45 am Purchase | 2023-12-26 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | Knoll Capital Management LLC | 3,881,879 9.967% | 3,799,070 (+4587.74%) | Filing |
| 2021-06-14 12:58 pm Purchase | 2021-05-19 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | Knoll Capital Management LLC | 82,809 10.400% | 24,764 (+42.66%) | Filing |
| 2021-02-16 2:48 pm Purchase | 2020-12-31 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | Knoll Capital Management LLC | 58,045 8.300% | 58,045 (New Position) | Filing |